Currency:JPYNov 8, 2024
Revenue
EPS
EBIT
No Data
BrightPath Biotherapeutics: Confirmation letter
Nov 8 14:35
BrightPath Biotherapeutics: Half Year Report - Term 22 (2024/04/01 - 2025/03/31)
Nov 8 14:34
BrightPath Biotherapeutics: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (unconsolidated)
Nov 8 14:30
BrightPath Biotherapeutics: 1Q financial results briefing for March 2025 [Japan standard] (non-consolidated).
Aug 9 14:00
Read more